<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29509905</article-id>
<article-id pub-id-type="pmc">5961083</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddy078</article-id>
<article-id pub-id-type="publisher-id">ddy078</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dysregulation of <italic>TBX1</italic> dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hasten</surname>
<given-names>Erica</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff1">1</xref>
<xref ref-type="author-notes" rid="ddy078-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDonald-McGinn</surname>
<given-names>Donna M</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff2">2</xref>
<xref ref-type="author-notes" rid="ddy078-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crowley</surname>
<given-names>Terrence B</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zackai</surname>
<given-names>Elaine</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Emanuel</surname>
<given-names>Beverly S</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrow</surname>
<given-names>Bernice E</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff1">1</xref>
<xref ref-type="corresp" rid="ddy078-cor1"></xref>
<!--<email>bernice.morrow@einstein.yu.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Racedo</surname>
<given-names>Silvia E</given-names>
</name>
<xref ref-type="aff" rid="ddy078-aff1">1</xref>
</contrib>
</contrib-group>
<aff id="ddy078-aff1"><label>1</label>Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA</aff>
<aff id="ddy078-aff2"><label>2</label>Division of Human Genetics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</aff>
<author-notes>
<fn id="ddy078-FM1">
<p>Erica Hasten and Donna M. McDonald-McGinn contributed equally to this work.</p>
</fn>
<corresp id="ddy078-cor1">To whom correspondence should be addressed at: Department of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Ave, Bronx, NY 10461, USA. Tel: +1 7186781121; Fax: +1 7186781016; Email: <email>bernice.morrow@einstein.yu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-03-02" pub-type="epub">
<day>02</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>11</issue>
<fpage>1847</fpage>
<lpage>1857</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">https://academic.oup.com/journals/pages/about_us/legal/notices</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddy078.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Non-allelic homologous recombination events on chromosome 22q11.2 during meiosis can result in either the deletion (22q11.2DS) or duplication (22q11.2DupS) syndrome. Although the spectrum and frequency of congenital heart disease (CHD) are known for 22q11.2DS, there is less known for 22q11.2DupS. We now evaluated cardiac phenotypes in 235 subjects with 22q11.2DupS including 102 subjects we collected and 133 subjects that were previously reported as a confirmation and found 25% have CHD, mostly affecting the cardiac outflow tract (OFT). Previous studies have shown that global loss or gain of function (LOF; GOF) of mouse <italic>Tbx1</italic>, encoding a T-box transcription factor mapping to the region of synteny to 22q11.2, results in similar OFT defects. To further evaluate <italic>Tbx1</italic> function in the progenitor cells forming the cardiac OFT, termed the anterior heart field, <italic>Tbx1</italic> was overexpressed using the <italic>Mef2c-AHF-Cre</italic> driver (<italic>Tbx1</italic> GOF). Here we found that all resulting conditional GOF embryos had a persistent truncus arteriosus (PTA), similar to what was previously reported for conditional <italic>Tbx1</italic> LOF mutant embryos. To understand the basis for the PTA in the conditional GOF embryos, we found that proliferation in the <italic>Mef2c-AHF-Cre</italic> lineage cells before migrating to the heart, was reduced and critical genes were oppositely changed in this tissue in <italic>Tbx1 GOF</italic> embryos versus conditional LOF embryos. These results suggest that a major function of <italic>TBX1</italic> in the AHF is to maintain the normal balance of expression of key cardiac developmental genes required to form the aorta and pulmonary trunk, which is disrupted in 22q11.2DS and 22q11.2DupS.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>P01HD070454</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">AHA</named-content>
<named-content content-type="funder-identifier">10.13039/100000968</named-content>
</funding-source>
<award-id>12POST9100003</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="11"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>